Evropská unie - slovinština - EMA (European Medicines Agency)

mylan pharmaceuticals limited - atazanavir (as sulfate) - okužbe z virusom hiv - antivirusi za sistemsko uporabo - atazanavir mylan, co-daje z nizkim odmerkom ritonavir, je indicirano za zdravljenje okužbe z virusom hiv 1 okuženih odraslih in pediatričnih bolnikih 6 let starosti in starejših v kombinaciji z drugimi protiretrovirusnimi zdravili. na podlagi razpoložljivih virological in kliničnih podatkov odraslih bolnikih, nobene koristi ni pričakovati pri bolnikih s sevi, odporni na več protease inhibitorji (≥ 4 pi mutacije). otroci, stari od 6 let do manj kot 18 let, so na voljo zelo omejeni podatki. izbira atazanavir mylan v zdravljenje izkušenih odraslih in pediatričnih bolnikih mora temeljiti na posameznih virusnih odpornost testiranje in bolnika v zdravljenje zgodovina.

Evropská unie - slovinština - EMA (European Medicines Agency)

mylan pharmaceuticals limited - prasugrel besilate - myocardial infarction; acute coronary syndrome; angina, unstable - antitrombotična sredstva - prasugrel mylan, co daje z acetilsalicilne kisline (asa), je označen za preprečevanje atherothrombotic dogodkov pri odraslih bolnikih s akutni koronarni sindrom (i. nestabilna angina pektoris, ki niso-st segmentu višinskih miokardni infarkt [ua/nstemi] ali st segmentu višinskih miokardni infarkt [stemi]) v procesu primarne zamudo ali perkutani koronarni intervenciji (pci).

Evropská unie - slovinština - EMA (European Medicines Agency)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotična sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Evropská unie - slovinština - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - multiplo sklerozo, recidivno-nakazila - imunosupresivi - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Slovinsko - slovinština - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - atorvastatin - filmsko obložena tableta - atorvastatin 20 mg / 1 tableta kalcijev atorvastatinat - atorvastatin

Slovinsko - slovinština - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - atorvastatin - filmsko obložena tableta - atorvastatin 80 mg / 1 tableta - atorvastatin

Slovinsko - slovinština - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - atorvastatin - filmsko obložena tableta - atorvastatin 20 mg / 1 tableta - atorvastatin

Slovinsko - slovinština - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - atorvastatin - filmsko obložena tableta - atorvastatin 40 mg / 1 tableta - atorvastatin

Slovinsko - slovinština - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva pharma b.v. - atorvastatin - filmsko obložena tableta - atorvastatin 10 mg / 1 tableta - atorvastatin

Slovinsko - slovinština - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

teva pharma b.v. - atorvastatin - filmsko obložena tableta - atorvastatin 40 mg / 1 tableta - atorvastatin